Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Neurologic Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Neurologic Other
    MRI Can Predict Outcome of Infants Deficient of Oxygen at Birth - (DGNews)
    Brain Tumours In Childhood Leave a Lasting Mark On Cognition, Life Status - (DGNews)
    Rifaximin Protects Patients With Cirrhosis From Breakthrough Hepatic Encephalopathy Over Long Term: Presented at AASLD - (DGDispatch)
    Neurocognitive Issues Plague HIV-Infected Patients Taking Antiretroviral Therapy: Presented at IDSA - (DGDispatch)
    Vaccine Inoculations Show No Link to Autism, Other Health Problems: Presented at IDSA - (DGDispatch)

    News archive

     Recent webcasts/CME - Neurologic Other
      Therapeutic Hypothermia
      Arteriovenous Malformations Dural Arteriovenous Shunts
      PreAnesthetic Assessment of the Patient with Neurotrauma
      Generalized Convulsive Status Epilepticus Guillain Barre Syndrome
      High-Risk Transient Ischemic Attacks Clinical Uses of Transcranial Doppler

      Webcasts/CME archive

       Recent cases - Neurologic Other
        Giant Thoracic Schwannoma Presenting with Abrupt Onset of Abdominal Pain: A Case Report
        Atypical Imaging Findings in a Renal Transplant Patient with Reversible Posterior Leukoencephalopathy Syndrome: A Case Report
        Reversible Cerebellar Syndrome Caused by Metronidazole
        A Patient with Typical Clinical Features of Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS) but Without an Obvious Genetic Cause: A Case Report
        Spinal Subdural Haematoma in Association With Anticoagulant Therapy, an Unusual Presentation. A Case Report and Review of Literature

        Cases archive
          




        my personal edition > neurologic other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Brain Surgery Associated With Cognitive Improvement: Presented at AANS

        By Norra MacReady

        SAN FRANCISCO, C.A. -- April 27, 2006 -- Surgical resection may improve cognitive function in people with brain tumors, according to findings from a poster presented here at the annual meeting of the American Association of Neurological Surgeons (AANS).

        According to the National Brain Tumor Foundation, more than 190,000 people are diagnosed with a brain tumor in the United States each year. The tumors often produce a rapid decline in thinking, speech, memory, and other cognitive functions that may rival Alzheimer's disease in severity. The speed and degree of impairment depend on the tumor's size, location and growth rate.

        These effects are especially poignant given the poor prognosis for many of these patients. Their life expectancy may be a little as 6 to 12 months, and the cognitive effects may curtail their ability to spend their remaining days with their loved ones.

        Surgery is the treatment of choice in most cases, but it is thought to exacerbate cognitive decline.

        To determine the effect of surgical resection on these patients, Elana Farace, PhD, associate professor of neurosurgery and health evaluation sciences, Pennsylvania State University, University Park, Charlottesville, Pennsylvania, United States, and colleagues evaluated 25 patients with primary brain tumors who underwent surgical resection.

        Study subjects had a variety of tumor types, such as craniopharyngioma, meningioma, central neurocytoma, colloidal cyst, and gliomas that ranged in severity from grade I to IV. The median age at diagnosis was 39 years.

        Patients underwent a standard neuropsychological evaluation before surgery and at 6 weeks post-surgery. The evaluation measured a broad range of domains, including attention, memory, executive function, visual and verbal memory, psychomotor speed, and depression. The scores were adjusted for patient demographics, using test norms where available.

        At the postoperative evaluation, 84% of patients had improved in at least 1 domain by at least 1 standard deviation, while 36% of the cohort had deteriorated. The percentages overlap because some patients improved in one domain and declined in another, the authors explained. Memory was the domain most likely to show improvement.

        Surgery is associated with a variety of risks and complications, like hemorrhage or damage to the surrounding brain tissue, which could worsen neurocognitive function. On the other hand, as these findings demonstrate, it may also improve function, the investigators wrote in their poster.

        Possible salutary mechanisms include resolution of mass effect, relief of intracranial pressure, or an effect of debulking. More research is needed to understand completely the cognitive effects of brain tumor resection, they wrote.


        [Presentation title: Neurocognitive Improvement Following Surgical Resection in Patients with Primary Brain Tumors. Poster 1437]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send